Sidra Khalid

Ms. Sidra Khalid


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2022 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
SASoumayya Aib
Soumayya Aib
Kashif IqbalKashif Iqbal
Kashif Iqbal
NKNasir Khan
Nasir Khan
SKSidra Khalid
Sidra Khalid
MAMuhammad Adnan
Muhammad Adnan
MDM. Junaid Dar
M. Junaid Dar

29 October 2024 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
SKSidra Khalid
Sidra Khalid
SBShahid Bashir
Shahid Bashir
RMRiffat Mehboob
Riffat Mehboob
TATehreem Anwar
Tehreem Anwar
MAMuhammad Ali
Muhammad Ali
SBShahnai Basharat
Shahnai Basharat
Objectives: Diabetes mellitus is a metabolic condition with hyperglycemia. Literature has shown a correlation between poor sleep quality and duration with an increased incidence of insomnia in diabetic individuals. The goal of this study was to determine the magnesium and potassium supplementation effect among diabetic individuals with insomnia.Methods: A randomized controlled trial (single blind) was conducted on 320 patients with diabetes; after 2 months of follow-up, 290 patients completed the trial. The Insomnia Severity Index (ISI) was used to assess the severity and duration of insomnia, before and after the trial. Tablets containing supplements were prepared: placebo (T1), magnesium (Mg, T2), potassium (K, T3), and a combination of Mg and K (T4). Melatonin and cortisol (sleep hormones) were measured from blood (serum) using an enzyme-linked immunosorbent assay (ELISA), before and after the trial.Results: The study included 93 (32.1%) male and 197 (67.9%) female participants. According to the analysis, there was a significant association between the treatment groups and ISI after the trial (post-trial), p = 0.0001. Analysis showed that there was significant association between pre- and post-serum cortisol levels in treatment groups 2, 3, and 4 (T2, T3, and T4) as p-values are 0.001, 0.001, and 0.001 respectively. Similar findings were observed for serum melatonin.Conclusions: The study revealed that magnesium, potassium, and magnesium and potassium combined had a significant effect on serum cortisol and melatonin levels (sleep hormones). In addition, supplementation significantly decreased the severity of insomnia among patients with diabetes by improving sleep duration.

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
RMRiffat Mehboob
Riffat Mehboob
SGSyed Amir Gilani
Syed Amir Gilani
Amber HassanAmber Hassan
Amber Hassan
SASadaf
Sadaf
ITImrana Tanvir
Imrana Tanvir
Miguel MuñozMiguel Muñoz
Miguel Muñoz
Expression and immunolocalization of Substance P (SP)/Neurokinin‐1 Receptor (NK‐1R) in breast carcinoma (BC) patients and its association with routine proliferative markers (ER, PR, HER2/neu, and Ki‐67) were evaluated. A cross‐sectional study was performed on 34 cases of BC. There were 23 cases of group A (grade III), 8 of group B (grade II), and only 3 cases of group C (grade I). All samples were then processed for SP and NK‐1R immunohistochemistry for few cases. 14/23 cases (61%) of group A, 7/8 cases (88%) of group B, and 2/3 (67%) cases of group C were SP positive. Overall, strong staining (≥10% tumor cells), labeled as “+3,” was observed in 9/14 (64.2%) cases of group A and 1/8 (12.5%) cases of group B. Moderate staining labelled as “+2” (in ≥10% tumor cells) was observed in 3/14 (21.4%) cases of group A and 4/8 (50%) cases of group B. Weak positive staining “+1” was observed in only 2/14 (14.28%) cases of group A, 2/8 (25%) cases of group B, and all 2/2 (100%) cases of group C. SP and NK‐1R are overexpressed in breast carcinomas, and there is significant association between the grade of tumor and their overexpression.

1 April 2021 in International Journal of Biosciences (IJB)
Verified
Journal Article
Open access
PDF file
FZFatima Zahra
Fatima Zahra
SKSidra Khalid
Sidra Khalid
MAMaria Aslam
Maria Aslam
ZSZainab Sharmeen
Zainab Sharmeen
Banana is a very delicious and nutritious fruit, economically more affordable in all over the world for all age groups from the Musaceae family. It belongs to the genus Musa. Banana is easily digestible, have low fat, sufficient amount of minerals and vitamins therefore used in special diets as for babies, patient having stomach disorders, arthritis. Every part of banana plant has specific health benefits, used to treat and prevent different diseases like cancer, ulcer, Alzheimer’s disease, infection, diarrhea, hemorrhoids, diabetes, and hypertension due to its antifungal, antibiotic, antimicrobial, antidiabetic, antioxidant, and anti-inflammatory properties. The unripe banana cooked form called plantains used as vegetable in some countries, useful for ulcer and digestive disorder. The leaves of banana plant are used for skin allergies, skin burns and flower of banana for bronchitis, diabetes, insect’s bites. The peel and pulp have dopamine, norepinephrine, serotonin which is effective for the smoothness of muscles of intestine and vitamin c of banana peel helps to get rid from free radical and protect the body from disease attack. The purpose of writing this review article to study the benefits of nutrients present in banana like phenols, flavonoids, phytochemicals, potassium, vitamins, fiber on human health.

15 October 2024 in Endocrinology, Diabetes & Metabolism
Verified
Journal Article
Open access
SKSidra Khalid
Sidra Khalid
RMRiffat Mehboob
Riffat Mehboob
SBSyeda Shazia Bokhari
Syeda Shazia Bokhari
MAMuhammad Ali
Muhammad Ali
ASAmbreen Shabbir
Ambreen Shabbir
BABander Alshehri
Bander Alshehri
Previous studies exploring the relationship between dietary potassium and magnesium intake and the risk of type 2 diabetes mellitus (T2DM) have yielded inconsistent results.Objective: The present study was designed to compare the effect of magnesium, potassium and both (potassium and magnesium combined) on cholesterol levels and quality of life (QoL) among patients with T2DM.Methods: A randomised controlled trial (single blinded) was conducted at The University of Lahore and Lahore Medical Research Center (LMRC). The sample size was 290 patients with T2DM, who were divided into four groups: Group I (T1) that received control/placebo; Group II (T2) and Group III (T3) received magnesium and potassium supplements, respectively; and Group IV (T4) received both magnesium and potassium supplements. Blood samples were taken from all patients before and after 60 days of supplementation to determine the levels of K+, Mg2+ and cholesterol using a chemistry analyzer (photometer 5010 v5+).Results: There was a decrease in mean cholesterol levels in all groups after the treatment, with the largest reduction (224.9 ± 61.92 to 163.4 ± 48.38) seen in the T3 group, that received potassium supplements. A significant increase in the social QoL, indicated by a p value change from 0.06 before medical intervention to 0.000 after medical intervention, was observed. p value was significant (<0.05) between pre‐ and post‐QoL within the T2 (Mg) and T3 (K) treatment groups.Conclusions: The overall decrease in cholesterol levels and improvement in the social QoL after treatment imply that magnesium‐ and potassium‐based formulations prove beneficial in combating hyperlipidaemia in patients with T2DM.Trial Registration: NCT04642313

1 December 2023 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
SKSidra Khalid
Sidra Khalid
SBShahid Bashir
Shahid Bashir
SBShahnai Basharat
Shahnai Basharat
RMRiffat Mehboob
Riffat Mehboob
TATehreem Anwar
Tehreem Anwar
SGShakira Ghazanfar
Shakira Ghazanfar
Background: Magnesium and potassium are two critical minerals that have been linked to the treatment of diabetes and its consequences. A lack of magnesium has been linked to insulin resistance and diabetes, whereas potassium has been found to promote insulin sensitivity and glucose metabolism. The study aimed to determine the relationship between cholesterol, liver and kidney markers, and quality of life in diabetic patients before and after magnesium and potassium supplementation. Methods: It was a single-blind randomized controlled study at Lahore Garrison University and Lahore Medical Research Centre (LMRC). The study included 200 diabetes participants. Four groups were made based on supplements. Blood samples of all diabetes patients were obtained to assess their quality of life before and after using Mg + and K + supplements, as well as the association between cholesterol, liver, and kidney markers. Results: The participants' average age was 51.0 ± 11.08. 139 (69.5 %) of the 200 participants were female, whereas 26 (30.5 %) were male. There was no correlation between the quality of life measure and the patients' cholesterol levels before and after the magnesium and potassium supplementation. Furthermore, the kidney and liver indicators were not dependent on the diabetes individuals' cholesterol levels. Conclusions: The study concluded that none of the four groups noticed a significant effect of magnesium and potassium therapies on the patient's quality of life or cholesterol levels. However, more research is needed to determine if liver and kidney problems are linked to cholesterol levels before and after medication, as the current study found no significant correlation between the two parameters.